Fairtility is powering in vitro fertilization (IVF) through transparent artificial intelligence to improve outcomes. It allows to reduce the number of IVF cycles to live birth, minimize the emotional, physical and financial burden on prospective parents, and enable collaborative discussions between clinicians and patients. CHLOE (Cultivating Human Life through Optimal Embryos) is a transparent AI-based decision support tool that provides clinicians with complete visibility into the clinical and laboratory parameters that make up data output to help improve IVF outcomes. Beginning with CHLOE EQ, a proprietary embryo grading platform, Fairtility is on a path to expand CHLOE's application to span the full IVF journey, from infertility cause assessment through transfer optimization.